Answers are grounded in this paper and cite their sources.
Natural killer (NK) cell-based immunotherapy is being explored for treating infectious diseases, including viral infections. Here, we discuss evidence of NK cell responses to different viruses, ongoing clinical efforts to treat such infections with NK cell products, and review platforms to generate NK cell products.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: